Clinical Trial Update: Alzheimer's Disease: Therapeutic Potential of Estrogen [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update evaluating the therapeutic potential of estrogen for Alzheimer’s disease in Phase 2/Phase 3 has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Estrogen (Estrogen)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Alzheimer Disease | Phase 2, Phase 3 | Status: COMPLETED